GXE:ETR
Lakefront Biotherapeutics NV
€ २६.०६
arrow_downward
-०.३१%(-०.०८०) 1D
अक्टोबर १५, ०९:०४:५२ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GXE...
Open
€ २६.०६
High
€ २६.०६
Low
€ २६.०६
Mkt. cap
१.७१ अरब
Avg. vol.
६०२.००
Volume
५८४.००
P/E ratio
२.८८
52-wk high
€ ३०.०२
52-wk low
€ २२.८४
EPS
€ ९.०५
No. of employees
१९६
Open
€ २६.०६
High
€ २६.०६
Low
€ २६.०६
Mkt. cap
१.७१ अरब
Avg. vol.
६०२.००
Volume
५८४.००
P/E ratio
२.८८
52-wk high
€ ३०.०२
52-wk low
€ २२.८४
EPS
€ ९.०५
No. of employees
१९६
News stories
From web sources and news partners
Yahoo Finance
·
४२ मिनेट पहिले
S&P 500's march to 8,000 hinges on 'very, very strong' third quarter
The Motley Fool
·
९ मिनेट पहिले
History Says Berkshire Hathaway Stock Holds Up When the Market Falls: It Beat the S&P 500 in 11 of 13 Down Years
CNN
·
२४ मिनेट पहिले
Global tech selloff deepens as enthusiasm for AI stocks wobbles
Stocktwits
·
२ घण्टा पहिले
Why Are Nasdaq Futures Sinking Premarket? CRWV, MU, TSM, SKHY, IBRX, RKLB, TSLA Stocks In Focus
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV